Australia Extends Biosimilar Education Efforts
GBMA-Led Biosimilar Education Program Will Now Run To June 2022
Australia’s government has agreed to extend a successful biosimilar education initiative led by the local GBMA industry association.
You may also be interested in...
Australia’s GBMA off-patent industry association has welcomed the announcement of significant healthcare investment in the country’s federal budget.
A new reported commissioned by Australia’s Generic and Biosimilar Medicines Association shows a ‘marked increase’ in confidence for biosimilars among a number of different stakeholders.
A campaign aimed at raising awareness and educating international audiences about biosimilars will be run next week by the IGBA.